Form 4 holding
Director
Serina Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 17,443
- Estimated value
- $112,839
- Report date
- 12 Sep 2024
- Price
- $6.47
- Ownership
- By Spouse
Steven Mintz
Insider Reports History
- Reporting-owner location
- Alameda, CA
- Latest reporting-owner signature
-
/s/ Steven Mintz
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Steven Mintz
Form 4 holding
Director
Serina Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 12,257
- Estimated value
- $79,291
- Report date
- 12 Sep 2024
- Price
- $6.47
- Ownership
- Direct
Form 4 holding
Director
Serina Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 3,040
- Estimated value
- $19,666
- Report date
- 12 Sep 2024
- Price
- $6.47
- Ownership
- By Adult Child 1
Form 4 holding
Director
Serina Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 2,840
- Estimated value
- $18,372
- Report date
- 12 Sep 2024
- Price
- $6.47
- Ownership
- By Adult Child 2
Form 4 holding
Director
Serina Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 2,650
- Estimated value
- $17,143
- Report date
- 12 Sep 2024
- Price
- $6.47
- Ownership
- By Adult Child 3
Form 4 holding
Director
AgeX Therapeutics, Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 41,812
- Estimated value
- Report date
- 01 Apr 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Steven Mintz
4
SER
Serina Therapeutics, Inc.
- Report period
- 12 Sep 2024
- Transactions
- 1
- Transaction value
- +$38,814
- Accepted by SEC
- 16 Sep 2024, 18:53
- Role
- Director
- Next action
- Open filing details
4
SER
Serina Therapeutics, Inc.
- Report period
- 15 Aug 2024
- Transactions
- 5
- Transaction value
- +$58,928
- Accepted by SEC
- 19 Aug 2024, 18:55
- Role
- Director
- Next action
- Open filing details
4
SER
Serina Therapeutics, Inc.
- Report period
- 21 Jun 2024
- Transactions
- 2
- Transaction value
- +$70,900
- Accepted by SEC
- 27 Jun 2024, 20:26
- Role
- Director
- Next action
- Open filing details
4
SER
Serina Therapeutics, Inc.
- Report period
- 17 May 2024
- Transactions
- 6
- Transaction value
- +$120,827
- Accepted by SEC
- 23 May 2024, 17:07
- Role
- Director
- Next action
- Open filing details
4
SER
AgeX Therapeutics, Inc.
- Report period
- 01 Apr 2024
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 03 Apr 2024, 20:59
- Role
- Director
- Next action
- Open filing details
3
SER
AgeX Therapeutics, Inc.
- Report period
- 08 Jan 2024
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 18 Jan 2024, 17:29
- Role
- Director
- Next action
- Open filing details